ANF A and F delivers 2 percent Q1 2026 EPS beat shares fall 239 percent on muted investor sentiment KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today ACONW Aclarion WT investors await full quarterly earnings filings to evaluate core operational performance trends